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MicroRNAs are small non-coding RNAs that suppress gene expression through target
mRNA degradation or translation repression. Recent studies suggest that miRNA plays an
important role in multiple physiological and pathological processes in the nervous system.
In this review article, we described what is currently known about the mechanisms
in peripheral nerve regeneration on cellular and molecular levels. Recently, changes in
microRNA expression profiles have been detected in different injury models, and emerging
evidence strongly indicates that these changes promote neurons to survive by shifting
their physiology from maintaining structure and supporting synaptic transmission towards
a regenerative phenotype. We reviewed the putative mechanisms involved in miRNA
mediated post-transcriptional regulation and pointed out several areas where future
research is necessary to advance our understanding of how targeting miRNA machinery
can be used as a therapeutic approach for treating nerve injuries.
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OBSTACLES ON THE WAY OF PERIPHERAL NERVE
REGENERATION
Nerve injuries induce severe disability and greatly compromise
the quality of life. Injuries to peripheral nerves, occurring in
approximately 2.8% of trauma patients, cause partial or total loss
of motor, sensory and autonomic functions (Noble et al., 1998).
Peripheral nerve injury leads to axon discontinuity and degenera-
tion of myelinated fibers, which may eventually result in death of
axotomized neurons (Navarro et al., 2007; Schuning et al., 2009).
After peripheral nerve injury, the severed axons have the capa-
bility to regenerate and recover functional connections. However,
a number of clinical reports and experimental studies in recent
years also indicate that the rate of axonal regeneration is far from
satisfactory, especially after severe injuries (Navarro et al., 2007).
The first detailed description on the repair of transected nerve
trunks was recorded by Gabriele Ferrara in the sixteenth cen-
tury (Ferrara, 1596). He described applying gentle traction to the
retracted nerve stumps, suturing using an alcohol disinfected nee-
dle, and finally, insulating the sutured segment with a mixture
of oils. The injured limb was later immobilized to prevent dam-
age to the suture (Artico et al., 1996; Ngeow, 2010). The whole
procedure closely resembles modern surgical protocol, which
includes disinfection, appropriate identification of injured nerve
trunk, suturing, and wound immobilization (Artico et al., 1996;
Ngeow, 2010). Over the years, different procedures have been
developed to boost intrinsic neuronal growth properties. In par-
ticular, physical therapies have evolved, such as treadmill training,
resistance training, and swimming, which aim tomaintainmuscle
strength, relieve pain, and enhance functional recovery (Bonetti
et al., 2011). Electrical stimulations have been also developed
to facilitate rehabilitation after nerve injuries in animal models
and human patients (Nix and Hopf, 1983; Ahlborn et al., 2007;
Gordon et al., 2009b). In addition, pharmacological elevation of
cAMP and overexpression of neuronal growth-associated genes
such as GAP-43 or CAP-23 have been reported to accelerate axon
outgrowth and promote robust regeneration (Caroni et al., 1997;
Bomze et al., 2001; Cai et al., 2001).
Despite the technological advances and extensive research on
nerve regeneration, the functional outcome after nerve injury and
repair are generally still insufficient, particularly when sensory
functions are considered (Dahlin et al., 2009). The failure of func-
tional recovery after peripheral nerve injuries can be explained
by various factors. It can result from the damage to the neu-
ronal cell body due to axotomy, retrograde degeneration (Krarup
et al., 2002; Schmidhammer et al., 2007), and neuronal loss
(Witzel et al., 2005; Navarro et al., 2007). Since peripheral nerve
injuries inherently involve inflammatory component, regenera-
tive attempts over long distance are always impeded by connective
tissue scarring (Deumens et al., 2010; Ngeow, 2010). Underlying
diseases, such as diabetic generalized neuropathy, may impede
axonal regeneration as well (Stoll and Muller, 1999). Potentially,
failure of functional recovery may also result from the poor
specificity of re-innervation. The selectivity of axon-target recon-
nection plays an important role in the recovery of function after
nerve injury and regeneration. During the process of nerve regen-
eration, several sprouts emerge from each parent axon (Witzel
et al., 2005). When axons reconnect with the appropriate periph-
eral tissue, misdirected axonal sprouts are withdrawn gradually.
The pruning of supernumerary axonal sprouts helps to refine the
selectivity of axon-target reconnection. However, the later refine-
ment of distal reconnection and the re-innervation of targets
are often far from adequate. When inappropriate distal recon-
nection is established, disturbed sensory localization or limited
fine motor control is expected to follow (English et al., 2011).
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The failure of functional recovery may also stem from the slow
rate of axonal growth. At an average rate of 1–3mm/day for
axonal regeneration in mammals, weeks or even months could
be anticipated for signs of functional recovery (Gordon et al.,
2009a). The long time period required for the regeneration is
responsible for concomitant denervation atrophy of the target
tissue (Gordon et al., 2009a). If the denervated skeletal muscles
are replaced by adipose tissue, despite the fact that peripheral
axons can regenerate through the injury site, functional recovery
is severely compromised.
Currently, no medical treatment can overcome the limitations
in axonal regeneration, and ensure the recovery of normal sensory
and motor functions following nerve trauma, and it is a gen-
eral consensus that the standard treatment options have reached
a plateau (Navarro et al., 2007). Therefore, new therapeutic inter-
vention strategies for peripheral nerve repair are critically needed.
A better understanding of the molecular and cellular mecha-
nisms involved in successful axon regeneration and appropriate
target re-innervation would be most helpful in developing new
therapeutic applications.
ENDOGENOUSMECHANISMS THAT SUPPORT PERIPHERAL
AXON REGENERATION
Nerve injuries are powerful stimuli that lead to profound cellular
responses. Following an injury, axons and myelin sheaths distal to
the lesion site are degraded by a process ofWallerian degeneration
(Glass, 2004; Makwana and Raivich, 2005). Myelin breaks down
to vesicles, resulting in the collapse of the myelin sheath (Ngeow,
2010). Schwann cell cytoplasm withdraws from the myelin vesi-
cles and significantly decreases the synthesis of myelin lipids and
proteins between 12 and 48 h post the injury (Ngeow, 2010). Such
damage increases the permeability of the blood-nerve barrier,
which allows for the recruitment of macrophages to the site of
the injured nerve. Infiltrating macrophages and injury-activated
Schwann cells phagocytize the degenerative end products (Stoll
and Muller, 1999). Wallerian degeneration takes place during the
first few days. During this stage, elimination of myelin sheaths
is important, because it clears the regeneration-inhibitory fac-
tors associated with myelin (Skaper, 2005; Raivich andMakwana,
2007). At the same time, retrograde degeneration also takes place
at a short segment of the proximal nerve stump. The remaining
axons in the proximal nerve also exhibit a reduction in diame-
ter, followed by chromatolysis at the neuron soma and dendritic
arbor retraction (Hanz and Fainzilber, 2006; Navarro et al., 2007).
Chromatolysis, characterized by the loss and dispersion of the
Nissl bodies, reflects a reactive alteration in neuronal biochem-
istry and function, when the neuronal cells shift their functions
from the synthesis of proteins required for neurotransmission
to those required for regenerative axon growth (Deumens et al.,
2010).
Loss of axonal contact also triggers dedifferentiation and pro-
liferation of Schwann cells in the distal nerve (Karanth et al.,
2006; Navarro et al., 2007). Proliferated Schwann cells line up in
bands of Bungner, which later provide support for regenerating
axons (Geuna et al., 2009). Schwann cells not only pave a path
for regenerating axons to grow, they also attract injured neurons
by secreting neurotrophic factors, such as nerve growth factor
(NGF) (Ngeow, 2010). Proximal to the lesion, fine sprouts emerge
(Witzel et al., 2005) and using distal endoneurial tube as a guiding
structure, elongate in association with Schwann cells toward tar-
gets (Stoll and Muller, 1999; Navarro et al., 2007). In the absence
of a guiding structure, regenerating axons may form neuroma,
a growth composed of immature axonal sprouts and connective
tissue.
Finally, regenerated axons reconnect with target peripheral
tissue. Because several sprouts emerge from each parent axon,
supernumerary axonal sprouts will be withdrawn gradually dur-
ing the maturation of the nerve fiber (Witzel et al., 2005; Navarro
et al., 2007). The regenerated axons will have smaller caliber and
with shorter internodes than normal nerve structures (Geuna
et al., 2009). For successful regeneration, the axons are expected
to replace the distal nerve segment lost during degeneration.
However, more often than not, the regenerated axons do not
innervate target tissues adequately or relay information from sen-
sory receptor accurately, reducing the recovery of motor and
sensory functions, especially when the lesion is severe (Choi et al.,
2005; Bannerman and James, 2009). Usually, after nerve injury
and repair, the diameter of regenerated axons, as well as their con-
duction velocity and excitability remain below normal levels for
a long time. Consequently, this results in incomplete and inade-
quate functional recovery of reinnervated organs (Van Meeteren
et al., 1997; Xiao et al., 2007).
MOLECULAR BASES OF PERIPHERAL NERVE REGENERATION
Previous studies have demonstrated that to initiate a regener-
ative response to injury in the peripheral nerve system (PNS),
the neuron must shift its physiology from synaptic transmis-
sion and maintenance of structure to the growth of the axon
(Benowitz and Yin, 2007). A sequence of molecular responses
would take place in response to injury for the successful nerve
regeneration and recovery of function (Figure 1). After nerve
lesion, calcium and sodium ions influx into axoplasm through the
ruptured plasmatic membrane, generating high frequency burst
of action potentials at the lesioned site (Makwana and Raivich,
2005; Navarro et al., 2007). This first signal promotes an influx
of calcium through voltage-dependent ion channels, and leads to
the activation of several protein kinase pathways, including: cal-
cium/calmodulin dependent kinase 2 (CMAK2), protein kinase
A (PKA), protein kinase C (PKC), and mitogen-activated protein
kinase (MAPK), such as Erk1 and Erk2, c-jun N-terminal kinase
(JNK) and P38 kinase (Makwana and Raivich, 2005; Raivich and
Makwana, 2007). During the second phase of signaling, these
activated proteins, termed “positive injury signals,” incorporate
the retrograde transport system for trafficking back to the cell
body from the injured site and induce several signaling pathways
genes (Hanz and Fainzilber, 2006). Several transcription factors
have been identified as the mediators in the regulation of gene
expression. The change in activity of transcription factors is con-
sidered the downstream event influenced by axotomy-activated
protein kinases (Dahlin et al., 2009). The activation of transcrip-
tion factor cAMP responsive element binding protein (CREB)
has been demonstrated in early stages after injury (Miletic et al.,
2004b). Phosphorylation of CREB can be mediated by multiple
protein kinase pathways through activation of tyrosine kinase
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FIGURE 1 | Signal transduction in neuronal cells after nerve injury. The
schematic diagram depicts several important signaling pathways activated
by axon injury. Cellular injury induces sodium and calcium influx, which lead
to depolarization. Among many other processes, the elevated intracellular
calcium concentration leads to the activation of protein kinase pathways
such as the MAPK Erk1 and Erk2, JNK, and P38 kinase. Downstream
events influenced by axotomy-activated kinases include up-regulation or
activation of several transcription factors. The modifications in the activity
of transcription factors result in characteristic changes of gene expression
in the injured and regenerating neurons.
receptors (Trk) (Miletic et al., 2004a). Two other transcription
factors induced by nerve injury are ATF-3 and c-Jun. c-Jun up-
regulation and phosphorylation is induced by activated JNK,
leading to the formation of activating protein 1 (AP-1) complexes.
JNK pathways and the Erk1/2 pathways also show cross-talk coor-
dinated by MEKK1 in PC12 cells (Waetzig and Herdegen, 2005).
ATF-3 is induced in all dorsal root ganglia (DRG) neurons after
peripheral axotomy, whichmakes it a reliable nerve injurymarker.
Inhibition of JNK reduces ATF-3 expression, which impairs nerve
regeneration (Dahlin et al., 2009). The modifications in the activ-
ity of transcription factors result in characteristic changes of gene
expression. Hundreds of genes have been found differentially
expressed after a nerve injury, including genes encoding for tran-
scription factors, cytoskeletal proteins, cell adhesion and guidance
molecules, trophic factors and receptors, cytokines, neuropep-
tides and neurotransmitter synthesizing enzymes, ion channels,
and membrane transporters (Navarro et al., 2007; Raivich and
Makwana, 2007; Dziennis and Alkayed, 2008; Hou et al., 2008).
The changes in gene expression support the formation of new
growth cones and elongation of the regenerating axon, leading to
nerve regeneration. The changes in the gene expression that pro-
mote nerve regeneration could also be induces by factors released
by non-neuronal cells (Zigmond, 2012). One example is inter-
leukin (IL)-6, a member of cytokines family referred to as the
glycoprotein (gp) 130 family. Injury induced IL-6 activates the
phosphorylation of STAT3, and the expression of a set of respon-
sive genes (Heinrich et al., 2003). While the release of gp130
cytokines promotes nerve regeneration, IL-6 knockout impairs
the normal functional recovery after sciatic nerve injury (Zhong
et al., 1999; Yang et al., 2012).
POST-TRANSCRIPTIONAL REGULATION OF GENE
EXPRESSION
The discoveries of micro RNAs (miRNAs) and RNA interfer-
ence (RNAi) have revolutionized our understanding of post-
transcriptional regulation of gene expression and have provided
powerful tools for targeted gene silencing.
The phenomenon of post-transcriptional regulation of gene
expression by small RNAs was first observed in petunia. When an
exogenous RNA sequence was introduced into petunia, instead
of being translated into protein, it “silenced” the endogenous
homologous gene’s expression (Napoli et al., 1990). This gene-
silencing phenomenon was then characterized in Caenorhabditis
elegans by Andrew Fire and Craig Mello, which they termed
“RNAi” (Fire et al., 1998). Subsequent studies have also
shown that long double-stranded RNAs (dsRNAs) can induce
a sequence-specific inhibition of gene expression in a number
of invertebrates, whereas shorter dsRNA, termed small interfer-
ing RNAs (siRNAs), are required to induce highly specific gene
silencing in mammalian cells (Elbashir et al., 2001).
RNAi is an evolutionary conserved mechanism to selectively
suppress gene expression (Filipowicz et al., 2008). It was origi-
nally recognized as a defensive response to foreign nucleic acids.
Eukaryotic cells infected by viruses can process the dsRNA car-
ried by viruses into siRNAs, which bind to and cause degradation
of matched messenger RNA (mRNA), preventing the synthe-
sis of protein necessary for viral replication. RNAi also protect
the eukaryotic genome from endogenous transposable elements,
and it was later demonstrated that RNAi is required for normal
development (Saugstad, 2010). Both exogenous double-stranded
siRNA and endogenous single-stranded miRNA can initiate and
utilize the same RNAimachinery to produce gene silencing (Rana,
2007).
miRNA BIOGENESIS AND RISC ASSEMBLY
miRNAs are endogenous non-coding 21–23 nucleotide small
RNA molecules that regulate gene expression by binding to the
3′-untranslated region of target mRNAs, leading to their transla-
tional inhibition or degradation (Filipowicz et al., 2008; Carthew
and Sontheimer, 2009). miRNAs are encoded in genomic DNA,
located either in the introns of protein-coding genes or as inde-
pendent entities (Figure 2). miRNA genes are first transcribed
by RNA polymerase II into primary miRNA (pri-miRNAs).
A single pri-miRNAs often contains sequences for several differ-
ent miRNAs folded into imperfectly base-paired hairpin struc-
tures. Primary miRNAs are cleaved by enzymes, such as Drosha
and DGCR8, into ∼70 nucleotide hairpins known as precur-
sor miRNAs (pre-miRNAs). Alternatively, miRNA transcription
may occur from the introns of protein-coding genes, called
“mirtron” or “mitron.” Mitrons are spliced out from premature
mRNA to form pre-miRNAs (Sibley et al., 2012), which bypass
the Drosha/DGCR8 enzyme complex. Regardless of the initial
source, pre-miRNAs are then transported into the cytoplasm by
Exportin-5 where they are further processed by the endoribonu-
clease called Dicer. In mammals, Dicer forms a complex with
human immunodeficiency virus (HIV) transactivating response
RNA (TAR) binding protein (TRBP) and inD. melanogaster Dicer
complexes with Loquacious (Bernstein et al., 2001; Lee et al.,
www.frontiersin.org April 2013 | Volume 4 | Article 55 | 3
Wu and Murashov miRNAs in peripheral nerve regeneration
FIGURE 2 | Biogenesis of miRNAs. miRNAs are processed from precursor
molecules, which are either transcripts from independent miRNA genes
(pri-miRNA) or are a portion of introns of protein coding transcripts
(mitron). The precursor molecules are excised into pre-miRNA with a
hairpin structure. The final processing of pre-miRNA by Dicer yields miRNA
duplex. One strand of the duplex is degraded and the remaining mature
miRNA binds to Argonaute proteins to form RNA-induced silencing
complexes (RISCs). miRNAs target sequences within messenger RNAs,
causing repression of translation and subsequent degradation or storage of
mRNAs in P-bodies.
2003; Filipowicz et al., 2008). TRBP interacts with PACT (a pro-
tein activator of the interferon-induced protein kinase, PKR) to
mediate RNAi and micro-RNA processing (Kok et al., 2007). The
products of Dicer processing form miRNA duplexes with pro-
truding 2-nucleotide 3′ end. The strand with the 5′ terminus
located at the thermodynamically less-stable end of the duplex
is usually selected to function as a guide strand for the mature
miRNA, while the opposite strand (or “passenger”) is degraded.
Occasionally, both strands give rise to mature miRNA (Filipowicz
et al., 2008). They are designated as miR-X and miR-X∗, with the
less predominately expressed transcript indicated by an asterisk
(Saugstad, 2010).
The mature miRNA target specific mRNAs to either cause
degradation of the mRNA or inhibit protein translation via RNA
induced silencing complex (RISC), a ribonucleoprotein com-
plex associated with miRNA. Although, assembly of RISC is a
very dynamic process and is not well understood, proteins of
Argonaute (Ago) family are considered the most important com-
ponents of RISC (Peters and Meister, 2007; Filipowicz et al.,
2008). The number of Ago proteins differs between species. For
example, humans have eight Ago proteins, Drosophila have five,
and C. elegans express 27 Ago proteins (Sasaki et al., 2003; Peters
and Meister, 2007). In mammals, only Ago2 can cleave mRNA at
the center of the siRNA-mRNA duplex. The significance of Ago2
in the RNAi pathway is also evidenced by the significant reduc-
tion in RNAi function after Ago2 knockdown (Hammond et al.,
2001).
Apart from Ago proteins, RISC contains other regulatory
factors and effectors that mediate inhibitory function. The
fragile X mental retardation protein (FMRP) is one of the
conclusively identified subunits. Both miRNA and siRNA can co-
immunoprecipitate with FMRP. The FMRP belongs to the fragile
X gene family, which encodes three different proteins: FMRP,
FXR1, and FXR2. The loss-of-function mutations in the FMRP
gene results in fragile X syndrome (FXS), whereas the function of
FXR1 and FXR2 remains unknown. However, it is suspected that
all three fragile X protein functions similarly in regulating mRNA
stability by binding with ribosomes, and FXR1 and FXR2 has the
potential to associate with RISC as well (Siomi et al., 2004). Other
identified components of RISC include Gemin3 and Gemin4,
which are also part of the survival of motor neurons (SMN)
complex. The SMN complex plays a critical role in the assem-
bly of diverse ribonucleoprotein complexes in the nervous system.
The functions of Gemin3 and Gemin4 are speculated to be
involved in target mRNA recognition and translational repression
(Dostie et al., 2003; Battle et al., 2007). RISC also recruits P-100.
Some studies have demonstrated that P-100 may be a nuclease
in RISC since it showed ribonuclease activity (Sundstrom et al.,
2009).
THE miRNA TARGET mRNA INTERACTION
miRNAs in RISC form complementary base pairs with mRNAs
within their 3′-UTR, leading to their translational inhibition or
degradation (Carthew and Sontheimer, 2009). In plants miR-
NAs usually have a complete complementarity to target mRNA,
which triggers mRNA degradation. In animals, miRNAs do not
have a complete match to mRNA and therefore miRNA-mRNA
binding causes translational block. The translational repression is
triggered by binding of the miRNA seed region to mRNA. The
primary rule for mRNA targeting is the perfect base pairing of
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the seed region, which is located at the miRNA nucleotides 2–8.
Perfect and contiguous Watson–Crick base pairing at this limited
region links miRNA with target mRNA (Filipowicz et al., 2008).
The second rule requires a mismatch to be present in the central
region of the miRNA-mRNA duplex. The bulge generated by the
mismatch precludes the Ago-2mediated endonucleolytic cleavage
of mRNA (Filipowicz et al., 2008). Some base pairing at the other
half side of miRNAs, especially the 13–16 nucleotides, would sta-
bilize the binding between miRNA and mRNA (Grimson et al.,
2007). Multiple miRNA binding sites within the mRNA 3′ UTR
can improve the silencing efficiency (Doench and Sharp, 2004).
A position of binding site close to the poly(A) tail or the ter-
mination codon increases the accessibility of mRNA to RISC
(Grimson et al., 2007). Interactions between proteins bound
to miRNA or mRNAs can also influence target selection and
efficiency of repression. However, because of the incomplete
match between miRNAs to mRNAs in animals, each miRNA
may potentially target numerous genes, which makes the pre-
diction of miRNAs targets complicated and usually insufficient
(Ritchie et al., 2009).
P-BODIES AS A SITES FOR miRNA MEDIATED
TRANSLATIONAL REPRESSION AND DEGRADATION
Several independent studies have shown that Ago proteins may
interact with the RNA-binding GW182 proteins (Sen and Blau,
2005; Eulalio et al., 2009; Takimoto et al., 2009). Subsequent
observations revealed that GW182-containing foci, known as
GW bodies (GWBs), coincide with mRNA-processing bodies or
P-bodies (Sen and Blau, 2005; Eulalio et al., 2009; Takimoto et al.,
2009). The cytoplasmic foci, termed P-bodies, serve as the sites
where mRNAs undergo degradation and storage (Ding and Han,
2007). In eukaryotes, mRNA degradation can follow two path-
ways that are initiated by a gradual shortening of the mRNA
poly(A) tail with deadenylases. In the first pathway, following
deadenylation, mRNAs are exonucleolytically digested from 3′
to 5′, which is catalyzed by the exosome (Eulalio et al., 2007b;
Filipowicz et al., 2008). In the second pathway, the cap structures
at 5′ end are removed by decapping enzymes after deadenyla-
tion, followed by 5′ to 3′ degradation catalyzed by exonuclease.
The decapping enzymes and decapping coactivator, including
DCP1 and DCP2, as well as exonuclease XRN1, colocalize in
P-bodies. Together they form the decaymachinery, which destabi-
lizes mRNAs in P-bodies (Eulalio et al., 2007a). The knockdown
of the decay machinery components prevents miRNA-mediated
degradation (Filipowicz et al., 2008). Additional P-bodies com-
ponents include: decapping activators RCK/p54 and Pat1, trans-
lational repressor eIF4E-transporter (4E-T), and RAP55. RAP55
responds to stress and has a putative role in translation regulation
(Eulalio et al., 2007b).
In addition to mRNA degradation, an alternative mecha-
nism to repress target mRNA expression is through transla-
tion inhibition. Translation requires the participation of several
initiation factors, many of which are multiprotein complexes.
Initiation of translation starts with the binding between mRNA
7-methylguanosine cap and eukaryotic translation initiation fac-
tor (eIF) 4E. When miRNA is bound to the mRNA 3′ UTR, Ago
proteins interact with the 7-methylguanosine cap of the mRNA.
The association of Ago, instead of eIF4E, with 7-methylguanosine
cap prevents effective recruitment of ribosomes and therefore
blocks the initiation of translation (Kiriakidou et al., 2007).
Furthermore, studies have also shown thatmultiple miRNA bind-
ing sites at the 3′ UTR increase the likelihood of Ago association
with 7-methylguanosine cap, thereby enhancing the translational
repression (Filipowicz et al., 2008). Association of Ago with 7-
methylguanosine cap also disrupts the 3D structure of the mRNA,
and possibly makes the poly (A) tail more vulnerable to exonucle-
olytic activity (Eulalio et al., 2007b).
Targeting translation initiation is not the only mechanism
miRNAs use to inhibit mRNA translation. The inhibition of
translation occurs at the post-initiation phase as well. Studies
have shown that mRNAs targeted by miRNAs remain associ-
ated with polysomes, despite a strong reduction in the protein
expression level (Filipowicz et al., 2008). miRNAs are speculated
to slow elongation and induce ribosome drop off from mRNA.
How miRNA could modulate the elongation or terminate the
translation of mRNA remains unclear.
Recent findings indicate that under certain conditions mRNAs
sequestered into P-bodies can be freed when cells respond to
a subsequent stress. The mRNAs released from P-bodies are
then recruited to the polysome and translation can be resumed
(Saugstad, 2010). The ability of miRNA to disengage from
repressed mRNA makes miRNA regulation more dynamic and
wide-ranging. One example in neuronal cells is miR-134 medi-
ated repression of LIMK1, a protein kinase that is important for
the development of dendritic spines. In response to extracellu-
lar stimuli, miR-134 mediated repression of LIMK1 is relieved at
dendritic spines (Schratt et al., 2006). This observation further
suggests that miRNA regulated mRNA translation is probably an
important regulator of gene expression in response to synaptic
activity.
FUNCTIONAL SIGNIFICANCE OF miRNAs
Bioinformatic predictions indicate that mammalian miRNAs can
regulate at least 30% of all protein coding genes (Filipowicz et al.,
2008). Therefore, it is no surprise that miRNA based regulations
are involved inmany cellular processes. miRNA plays diverse roles
in cell differentiation, proliferation (Stefani and Slack, 2008),
metabolism (Wang et al., 2011), and signal transduction
(McCoy, 2012).
miRNAs IN NEURAL DEVELOPMENT
Early studies revealed that decreasingmiRNAproduction byDicer
gene ablation induced embryonic lethality, suggesting miRNA
plays a critical role in normal fetal development (Bernstein et al.,
2003). The conditional Dicer knockout approaches showed piv-
otal role of miRNA in neural development. Dicer deletion in
neocortex disrupted differentiation of newborn neurons and
results in neuronal cell death (De Pietri Tonelli et al., 2008).
Dicer ablation in hippocampus at different embryonic time points
resulted in abnormal hippocampal morphology, and affected the
number of hippocampal progenitors due to altered prolifera-
tion and increased apoptosis (Li et al., 2011). Dicer-null neural
stem cells were incapable of generating either glial or neuronal
progeny, which blocked the differentiation (Andersson et al.,
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2010). Conditional knockouts for Dicer also resulted in the mal-
formation of the midbrain and cerebellum, and failure of neural
crest and dopaminergic differentiation in mice (Huang et al.,
2010).
miRNAs AS EFFECTORS IN NEUROLOGICAL DISORDERS
A number of studies have shown a correlation between neurolog-
ical diseases and the alteration of miRNA biogenesis. Although no
conclusion can be made that the altered expression of miRNAs is
a consequence or the cause of neurological disorders, some stud-
ies showed the change in miRNA expression prior to the onset of
the disease (Wang et al., 2008b). This raises the possibility that
restoring the expressing level of specific miRNAs could prevent
the pathological development of the diseases.
Mouse models and human samples have both implicated
altered miRNAs in the Alzheimer’s disease (AD), particularly with
respect to the regulation of β-amyloid precursor protein con-
verting enzyme1 (BACE1) (Hutchison et al., 2009). BACE1 was
shown to be targeted by miR-458-5p, and an endogenous natu-
ral BACE-antisense competes with miR-485-5p for the binding
on BACE1 mRNAs. In AD patients, BACE-antisense appeared
to be up-regulated while miR-485-5p was down-regulated in
cortex and hippocampus. Therefore, the down-regulation of
BACE1 translation was blocked, which stimulated the forma-
tion of amyloid-β-peptide plaques (Faghihi et al., 2010). miR-29
was found to regulate BACE1 expression in vitro, and decreased
expression of miR-29a and miR-29b was observed in AD brains
(Hebert and De Strooper, 2007; Hebert et al., 2008). In addi-
tion, miR-107 significantly decreases at early stage of AD, and
has multiple predicted binding sites on BACE1 (Wang et al.,
2008b). In mouse models, miR-298 and miR-328 can also tar-
get BACE1 mRNA, and in vitro studies confirm the regulation
of BACE1 protein expression by these miRNAs (Boissonneault
et al., 2009). Increased expression of miRNAs, such as miR-9,
miR-125b, miR-138, andmiR-146a have also been observed in AD
brains (Saugstad, 2010; Olde Loohuis et al., 2012).
The pathological development of Parkinson’s disease (PD) is
under the control of miRNAs as well. Conditional knockout of
Dicer in dopaminergic neurons results in the loss of dopaminergic
neurons and impaired locomotion, mimicking the phenotype
of PD patients (Olde Loohuis et al., 2012). Gene screen of PD
patients identified a disruption in the binding site of miR-433
in the 3′ UTR of the fibroblast growth factor 20 (FGF20) gene.
This disruption leads to an increased expression of FGF20 and
a subsequent increase of α-synuclein expression, which is corre-
lated with cytotoxicity associated with PD (Wang et al., 2008a).
Increased expression of α-synuclein may also result from insuffi-
cient expression of miR-7 in neurotoxin model of PD (Junn et al.,
2009). Another report found a significant decrease of miR-133b
expression in PD patients. Additional studies revealed that miR-
133b is specifically expressed in midbrain dopaminergic neurons,
and targets the transcription factor pituitary homeobox 3 (Pitx3).
Lack of miR-133 disrupted midbrain dopaminergic maturation
and function (Kim et al., 2007).
Studies on miRNA expression in Huntington’s disease (HD)
brains revealed dysregulated expression of several miRNAs in
both mouse models and human patients (Hutchison et al.,
2009). HD is related to abnormal activation of the transcrip-
tion factor REST. When Huntington protein cannot bind REST,
REST can freely translocate to the nucleus and repress neu-
ronal gene expression. Studies showed that several miRNAs
with REST binding sites or REST cofactor binding sites are
decreased in human HD, including miR-9 and miR-9∗, which
target REST and co-REST, respectively (Packer et al., 2008). miR-
124, which plays a role in maintaining neuronal identity through
targeting PtBP-1is also decreased in HD patients (Cao et al.,
2007).
Interestingly, intellectual disability syndromes and mental dis-
eases appear to be influenced by miRNA expression as well.
Studies in schizophrenia patients revealed a significant increase
in global miRNA expression (Beveridge et al., 2010). miR-160b,
30b, and 181b were significantly up-regulated in the frontal
cortex of schizophrenia patients (Kim et al., 2010; Santarelli
et al., 2011). NMDA-regulated miRNA miR-132 was significantly
down-regulated in the prefrontal cortical tissue from schizophre-
nia patients (Miller et al., 2012). Twenty-eight miRNAs are differ-
ently expressed in the brains of autistic patients, and the predicted
targets of dysregulated miRNAs include Neurexin and SHANK3,
which are known genetic causes of autism (Abu-Elneel et al.,
2008). In another study, differential expressions of nine miR-
NAs were observed in autism samples in growing lymphoblastoid
cell lines (Talebizadeh et al., 2008). These studies reveal a sub-
set of brain-related microRNAs implicated in schizophrenia and
autism.
miRNAs LOCATED IN NEURONS
In neurons, the functions of individual miRNAs are just begin-
ning to emerge. To date, seven miRNAs have been identified to be
specifically expressed inmammalian brain, which includesmiR-9,
miR-124a, miR-124b, miR-135, miR-153, miR-183, and miR-
219; suggesting their unique regulatory roles in brain function
(Sempere et al., 2004). Functional analysis showed that trans-
fection of brain-specific miR-124 into HeLa cells is sufficient to
shift the gene expression profile toward neuronal-like phenotype
(Lim et al., 2005). One direct target of miR-124 is small c-terminal
domain phosphatase 1, an anti-neural factor of REST/SCP1 path-
way. Suppression of small c-terminal domain phosphatase 1
induces neurogenesis during brain development (Visvanathan
et al., 2007). MiR-124 also represses the expression of SRY-box
transcription factor Sox9. This repression promotes adult neuro-
genesis in the subventricular zone stem cell niche (Cheng et al.,
2009). MiR-124 also regulates early neurogenesis in the forebrain
and optic vesicle by targeting NeuroD1 (Liu et al., 2011). More
recently, miRNA expression profiles have been identified within
brain regions, such as the cortex and hippocampus. It was found
that the expression of let-7g, miR-92b, miR-146b, miR-330∗, and
miR-394 were significantly higher in rat hippocampus than in
cortex (Olde Loohuis et al., 2012). The specificity in miRNA
expression further suggested the cell or tissue specific functions
of miRNAs. For example, miR-449 has been identified in the
choroid plexus, the area in the brain ventricle that is responsi-
ble for the production of cerebrospinal fluid. Transcription factor
E2f5, which regulates cerebrospinal fluid production is targeted
by miR-449 (Redshaw et al., 2009).
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miRNAs IN AXONS AND DENDRITES
Subcellular localization of miRNAs within neuronal dendrites
and axons has been shown in recent studies. With laser capture
microdissection, RNA populations from dendrites and cell bodies
were acquired. RT-qPCR analysis revealed that most miRNAs dis-
tributed with a gradient decrease from soma into the dendrites.
A few miRNAs, such as miR-26a, miR-26b, and miR-292-5p,
are enriched in dendrites (Kye et al., 2007). Enrichment of pre-
cursor miRNAs has been observed in dendrites as well. These
dendritically enriched precursor miRNAs show a distinct struc-
ture which may allow for binding to proteins that mediate den-
dritic transport (Smalheiser, 2008). The significant correlation
between precursor and mature miRNAs enrichments suggests
that precursor miRNAs may be processed locally in dendrites.
The identification of Dicer at postsynaptic densities further sup-
ports this hypothesis (Lugli et al., 2005, 2008). It has been widely
accepted that local protein synthesis in distal domains of neu-
ron has a key role in synaptic formation, synaptic plasticity, and
axonal regeneration (Schacher and Wu, 2002; Hanz et al., 2003).
Regulation of local mRNA translation can alter the synaptic pro-
tein expression upon stimulations. One theory for miRNA-based
regulation of local protein synthesis suggests that precursor miR-
NAs are predominantly associated with postsynaptic densities.
Upon stimulation neuronal-mediated calcium influxes activate
proteases, such as calpain, resulting in the release of Dicer from
the postsynaptic density. The newly freed Dicer processes pre-
cursor miRNAs into mature miRNAs, which then incorporate
into RISC and inhibit target mRNA translation. Meanwhile, acti-
vated proteases can also degrade components of RISC. mRNAs
that are important for synaptic plasticity can be released from
RISC and selectively enter the polysome compartment where
they will resume the initiation of translation. This local trans-
lational regulatory model provides a mechanism that meets the
requirements for both increased and decreased protein synthesis
(Saugstad, 2010).
A small number of miRNAs involved in synaptic mor-
phogenesis and plasticity have been identified through recent
functional analysis. miR-138 is localized in dendrites of rat
hippocampal neurons, and it inhibits dendrite spine growth
through activating the Rho signaling pathway. miR-138 tar-
gets acyl protein thioesterase 1 (APT1), which in turn cat-
alyzes the membrane association of Gα12/13. The membrane
association of small G protein subunit Gα13 has been shown
to be involved in the activation of RhoA signaling pathway
(Siegel et al., 2009). In contrary, miR-132 expression enhances
dendrite morphogenesis in hippocampal neurons. miR-132
represses the expression of the Rho GTPase-activating protein
(GAP) p250. p250GAP regulates spine formation by modulat-
ing Rac1 and RhoA activities. Therefore, miR-132 expression
is related to P250GAP. Introduction of miR-132 showed the
same effect on dendritic spine phenotype as p250GAP knock-
out, which results in increased spine density and size (Olde
Loohuis et al., 2012). miR-134 is an example of neurotrophic
control of dendritic spine plasticity through a miRNA mech-
anism. Localization of miR-134 to dendrites negatively regu-
lates the size of dendritic spine by inhibiting the expression of
LIM domain kinase 1(Limk1), neurogenic differentiation factor 2
(NeuroD2), and disks large homolog2 (DLG2). Exposure to
brain-derived neurotrophic factor (BDNF) relieves the inhi-
bition in spine development by miR-134, and increases the
expression of Limk1 protein. Limk1 regulates actin filament
dynamics, thereby controlling cytoskeletal reorganization, and
promoting new spine outgrowth (Schratt et al., 2006). The
involvement of miRNAs in synaptic plasticity is further con-
firmed with the changes of miRNA expressions after long-term
potentiation.
Compared with the studies on dendritic miRNAs, there
is less understanding in the role of miRNA in axonal func-
tions. However, the studies investigating axonal miRNA pathway
are growing. Pure axonal miRNAs have been obtained from
superior cervical ganglia neurons cultured in compartmental-
ized Campenot cell culture chambers. In total, 130 mature
miRNAs have been detected in distal axons, and a few, such
as, miR-15b, miR-16, and miR-221, were highly enriched in
axons (Natera-Naranjo et al., 2010). miRNA machinery com-
ponents, including Dicer, Ago proteins, and a fragile-X men-
tal retardation protein (FMRP), have been found to be local-
ized in developing axons and growth cones in RNA granule-
like structures (Hengst et al., 2006). Although direct evi-
dence for miRNA-mediated suppression of axonal mRNA trans-
lation has not been demonstrated, the involvement of the
miRNA pathway in the regulation of axonal function is sug-
gested by the functional activity of miRNA machinery in axons
(Hengst et al., 2006). The existence of protein components
of RISC was shown in sciatic nerves. Transfection of siRNA
against neuronal β-tubulin into axons initiated the formation
of RISC and the suppressions of target gene (Murashov et al.,
2007b).
INJURY INDUCED miRNA EXPRESSION AFTER PERIPHERAL
NERVE INJURY
The involvement of the miRNA biosynthetic machinery in the
regulation of intra-axonal local protein synthesis after injury
was confirmed by the injury-regulated expression of biosyn-
thetic enzymes, including components of RISC and P-bodies (Wu
et al., 2011). In particular, researchers observed an increase in
the number and the size of P-bodies in the regenerating DRG
axons after conditioning sciatic nerve lesion. The P-bodies were
primarily localized to the axon varicosities. The physiological role
of axon varicosities has been associated with places of organelle
accumulation and sequestration (Bennett and Muschol, 2009),
and clustering of excess growth resources (Malkinson and Spira,
2010). The varicosities were also identified as the sites of mRNA
concentration and protein synthesis (Lee and Hollenbeck, 2003).
Interestingly, the number of varicosities in the regenerating DRG
neurons was markedly higher than in naïve. Taken together, these
data suggest that P-body machinery localized to varicosities could
regulate the growth resources by managing mRNA pool (Wu
et al., 2011) (Figure 3).
Further studies showed that inducible deletion of Dicer
impaired nerve regeneration according to functional behavioral
tests, electrophysiological, and histological analyses in a mouse
model of peripheral nerve crush. In addition,Dicer-deficient neu-
rons failed to regenerate axons in DRG cultures after conditioning
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FIGURE 3 | A model for regulation of axonal protein synthesis by
miRNA in regeneration. The illustration depicts neuronal cell body, axon
varicosity and the growth cone. Pri-miRNA is transcribed in the nucleus
and transported to cytoplasm as pre-miRNA. In the cytoplasm, pre-miRNA
is processed by Dicer/TRBP complex into mature miRNA, which is loaded
onto RISC. RISC is a nucleoprotein complex, which may be transported to
distal regions of neuron including the growth cone. In the growth cone
RISC may regulate protein translation by silencing specific mRNAs and
causing translational repression. The repressed mRNAs may translocate
into P-body, a specific foci, primarily localized to axon varicosities. Axon
varicosity is a place of organelle accumulation (Bennett and Muschol,
2009), clustering of excess growth resources (Malkinson and Spira, 2010),
mRNA concentration (Lee and Hollenbeck, 2003), and P-body accumulation
(Wu et al., 2011). The P-body machinery localized to varicosities may
regulate the growth resources by managing mRNAs pool. In P-body,
mRNAs targeted for destruction are associated with decapping enzymes
Dcp1 and Dcp2, as well as GW182. Translationally repressed mRNA might
be also stored in P-body. Upon changes in cellular conditions and stimuli,
some of the stored mRNAs can re-enter the translation pathway
(Rana, 2007).
sciatic nerve lesion. Thus, this study demonstrated that the intact
Dicer-dependent miRNA pathway is critical for the successful
functional recovery in vivo and the regenerative axonogenesis
in vitro (Wu et al., 2012).
Furthermore, a group of miRNAs that are specifically
expressed in an injury-regulated pattern in the regenerating sci-
atic nerves and DRG were identified by miRNA microarrays
and confirmed by qPCR (Strickland et al., 2011; Wu et al.,
2011). The most upregulated miRNA, miR-21 has the abil-
ity to promote axon growth in adult DRG neurons through
targeting SPRY2 (Strickland et al., 2011). Overexpression of
miR-21 also protects against ischemic neuronal death, proba-
bly mediated by its downregulation of FASLG, an important
cell death-inducing ligand (Buller et al., 2010). The upregulated
miR-29b in sciatic nerves during nerve regeneration exhibited
neuronal protective effects (Kole et al., 2011). It was shown
that miR-29b functions as a novel inhibitor of neuronal apopto-
sis by targeting multiple proapoptotic BH3-3 gene family (Kole
et al., 2011). Some of the upregulated miRNAs have injury-
induced expression patterns in CNS as well, such as miR-211
and miR-142-5P. Their expression levels were increased after
brain injury or spinal injury, respectively (Lei et al., 2009; Liu
et al., 2009). The downregulated miRNA, miR-145, has been
shown to inhibit neurite outgrowth in vitro with robo2 and
srGAP2 validated as its potential target genes (Zhang et al.,
2011). Surprisingly, some miRNAs showed a decrease in their
expression level in the sciatic nerve microarray analysis corre-
lating with a positive effect on axon outgrowth, such as miR-
124a and miR-133. miR-124a decreased its level in sciatic nerves
after crush, however, it was required for hippocampal axono-
genesis through Lhx2 suppression, which also prevents apop-
tosis in the developing retina (Sanuki et al., 2011). In zebra
fish, miR-133 has been shown to promote tissue regeneration
by targeting the small GTPase RhoA, an inhibitor of axonal
growth (Yu et al., 2011). Since the sciatic nerve is a hetero-
geneous tissue, the changes in miRNA expression may result
from responses of both Schwann cells and neuronal cells to
the nerve injury. This partially explains why some of the array
data did not correlate well with the functions of the miRNA in
neuronal cells. Only miR-21 was upregulated in both array data,
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which further confirmed the spatial specificity in miRNA expres-
sion (Wu et al., 2011).
CONCLUSION
In the past decade, as one of themajor discoveries in the history of
molecular and cell biology, the post-transcriptional regulation of
gene expression has become a major focus of research. There has
been rapid progress in deciphering the mechanisms underlying
miRNA pathway. The understanding of miRNA pathway in neu-
roscience is growing through intensive investigation of a variety
of neurological events. Temporally and spatially specific miRNA
expression has been identified in neurodevelopment and in neu-
rological diseases (Martino et al., 2009; Smith et al., 2010; Martins
et al., 2011). In axonal compartments, the miRNAmachinery has
been shown to be present and is functional upon application of
siRNA to peripheral nerve fibers (Hengst et al., 2006; Murashov
et al., 2007a). More importantly, ablating the miRNA process-
ing negatively impacted peripheral nerve regeneration in vivo and
regenerative axon growth in vitro (Wu et al., 2012).
The importance of local protein synthesis for nerve regen-
eration has been shown by an increase in local translation of
proteins after peripheral nerve axotomy, and the observation
that inhibiting this synthesis greatly reduces the reproduction
of growth cones (Verma et al., 2005); however, the under-
lying mechanism responsible for the regulation of the local
protein synthesis is largely unknown. Emerging evidence sug-
gests miRNA could be one of the mechanisms that regulate
axonal protein synthesis after peripheral nerve injury. However,
we are only at the initial stage of understanding the role of
miRNA in nerve injury and regeneration. Studies deciphering
the functions mediated by miRNAs will have great significance
in understanding basic cellular mechanisms, as well as inspir-
ing miRNA-based therapeutics. As a mediator of gene silencing,
miRNA has already shown therapeutic efficacy in animal mod-
els of neurological conditions. Further work will be required
to elucidate how miRNA pathway contributes to peripheral
nerve regeneration and how to use it as a tool to treat nerve
injuries.
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